Time: Noon - 1:30 p.m. EDT
Charles R. Macedo, JD - Amster Rothstein & Ebenstein LLP
Brian J. Amos, JD, PhD - Amster Rothstein & Ebenstein LLP
In a unanimous decision on Helsinn v. Teva, the Court held that the sale of an invention to a third party, who is required to keep confidentiality, qualifies as prior art under the AIA.
This ruling will affect post-AIA patent practice and is expected to have a major impact on prosecution, other court cases, and Patent Trial and Appeal Board proceedings. Join us to learn how it will affect you and pitfalls to avoid.